Skip to main content
Contact Locations Diversity Pro Bono Our Story
Lingyin Ge

Lingyin Ge, PhD

(she/her/hers)
Associate | Biotechnology
617.646.8199 Lingyin.Ge@WolfGreenfield.com LinkedIn Profile

Education

  • MD, Clinical Medicine, Nanjing Medical University
  • PhD, Cellular and Molecular Biology, Stony Brook University
  • JD, Suffolk University Law School

Key Technologies

  • Gene Therapy
  • Antibody
  • Therapeutic Peptides
  • Antisense Oligonucleotides
  • Cell Therapy
  • Biomolecule Production
  • Gene Editing

Practice Groups

Languages

  • Mandarin Chinese

Admitted to Practice

  • Massachusetts
  • US Patent and Trademark Office

Location

  • Boston

Overview

Lingyin Ge assists the Biotechnology Practice in US and foreign patent preparation and prosecution, freedom-to-operate analysis, IP landscape analysis, and due diligence. She draws from her scientific background when assisting life sciences clients, including start-ups, mid-large size companies, and research institutions, with their intellectual property needs. 

Lingyin has extensive knowledge in the areas of gene therapy, antibodies, therapeutic peptides, antisense oligonucleotides, and biomolecule production.

Prior to joining Wolf Greenfield, Lingyin was a project scientist at Cedars-Sinai Medical Center. She conducted research on pulmonary fibrosis and lung injury. Lingyin also interned in the tech transfer office at Cedars-Sinai, where she evaluated patentability and marketability of disclosed therapeutic and medical device inventions and assisted external legal counsel in drafting patent applications and office action responses.

Lingyin received her PhD from Stony Brook University. Her research focused on DBP-Actin complex serves as Danger Associated Molecular Pattern (DAMPs) to induce acute lung injury in sepsis and trauma patients.

Experience

  • Assisted a leading pharmaceutical company to maintain and improve a patent portfolio and develop global prosecution strategy inline with client’s commercial interests
  • Assisted a start-up biotech company to build and expand patent portfolios to various programs

Activities

  • Boston Intellectual Property Law Association

Publications

Scientific Publications

  • Parimon T, Brauer R, Schlesinger SY, Xie T, Jiang D, Ge L, Huang Y, Birkland T, Parks WC, Habiel D, Hogaboam C, Gharib SA, Deng N, Liu Z, Chen P. Am J Pathol. 2018 Jan 31.
  • Ge L, Habiel DM, Hansbro PM, Kim RY, Gharib SA, Edelman JD, Konigshoff M, Parimon T, Brauer R, Huang Y, Allen J, Jiang D, Kurkciyan AA, Mizuno T, Stripp BR, Noble PW, Hogaboam CM, Chen P. JCI Insight. 2016 Dec  8.
  • Brauer R, Ge L, Schlesinger SY, Birkland TP, Huang Y, Parimon T, Lee V,  McKinney BL, McGuire JK, Parks WC, Chen P. Am J Respir Crit Care Med. 2016 Aug 1.
  • Gharib SA, Edelman JD, Ge L, Chen P. Transplant Direct. 2015 Nov;1(10).
  • Kirillov V, Siler JT, Ramadass M, Ge L, Davis J, Grant G, Nathan SD, Jarai G, Trujillo  G. Am J Pathol. 2015 Apr.
  • Ge L, Trujillo G, Miller EJ, Kew RR. Immunobiology. 2014 Mar.
  • Trujillo G, Habiel DM, Ge L, Ramadass M, Cooke NE, Kew RR. J Immunol. 2013 Jul 15.
  • Trujillo G, Zhang J, Habiel DM, Ge L, Ramadass M, Ghebrehiwet B, Kew RR. Mol Immunol. 2011 Dec.

Interests

I’m a zealous collector of minerals, gemstones, and rocks.

Top